Putnam Investments’s Precigen PGEN Stock Holding History

Putnam Investments’s Portfolio PGEN Stock Details PGEN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q3	–	Sell	-26,608	Closed	-$1.29M	–	1523
2015 Q2	$1.29M	Sell	26,608 -985	-4%	-$41.5K	﹤0.01%	1174
2015 Q1	$1.2M	Hold	27,593	–	–	﹤0.01%	1170
2014 Q4	$726K	Hold	27,593	–	–	﹤0.01%	1235
2014 Q3	$490K	Hold	27,593	–	–	﹤0.01%	1354
2014 Q2	$663K	Hold	27,593	–	–	﹤0.01%	1266
2014 Q1	$693K	Buy	27,593 +209	+0.8%	+$5.79K	﹤0.01%	1280
2013 Q4	$623K	Hold	27,384	–	–	﹤0.01%	1300
2013 Q3	$620K	Buy	+27,384	New	+$632K	﹤0.01%	1303

Other funds holding PGEN

Third Security Radford, Virginia $241M AUM 45.43% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

MVP

Miller Value Partners Sarasota, Florida $383M AUM 38.57% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

UOTTAIMCU

University of Texas/Texas AM Investment Management Co (UTIMCO) Austin, Texas $687M AUM 21.33% 1-Year Est. Return

IAM

Iridian Asset Management Westport, Connecticut $247M AUM 20.65% 1-Year Est. Return

First Trust Advisors Wheaton, Illinois $140B AUM 27.84% 1-Year Est. Return

Third Point New York $2.08B AUM 27.04% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Putnam Investments's PGEN Position: Q3 2015 in Review

Putnam Investments sold out of Precigen (PGEN) in Q3 2015, closing a stake of 26,608 shares — an estimated $1.29M sold.

Putnam Investments first reported a position in PGEN in Q3 2013 and held it in 8 quarters. The position peaked at $1.29M in Q2 2015. 173 funds tracked by Wall St. Rank hold PGEN as of Q3 2015.

Putnam Investments reported no remaining Precigen position as of Q3 2015 after selling out during the quarter.
Putnam Investments sold 26,608 Precigen shares in Q3 2015, an estimated $1.29M.
Putnam Investments first reported a position in Precigen in Q3 2013 and held it in 8 quarters.
Putnam Investments's Precigen position peaked at $1.29M in Q2 2015.
173 funds tracked by Wall St. Rank held Precigen as of Q3 2015.

Based on Putnam Investments's 13F filing for Q3 2015, filed 16 Nov 2015.